Anti-infective drug discovery doesn’t end with Covid-19
Over the last two years, the world’s focus has been on fighting Sars-CoV-2 and bringing us out of the most significant viral pandemic in over a century. While this activity has been crucial, it has also engendered a form of tunnel vision with respect to the awareness of ongoing global epidemics, particularly those facing the developing world – such as malaria. The Covid-19 pandemic has brought to the fore the necessary role of science, the impact of research and development and the importance of industrial and academic collaboration in addressing such problems that affect us all. MMV now needs your help to find new antimalarial drug candidates.